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Simulated  case-control  cerebral  blood  ﬂow  imaging  data  were  generated  from  arterial  spin  labelling  data  in  a cohort  of  older  adults.
This  study  presents  a methodology  by  which  one  can  trade off  sensitivity  and  speciﬁcity  when  designing  a perfusion  study  to detect  group  differences
at  a voxel-wise  level.
The  permutation  testing  algorithm  required  larger  sample  size  by  1.5–2 times  relative  to the  GLM  approach  to  detect  a  low  or moderate  perfusion
difference.
While  the permutation  testing  algorithm  required  a substantially  higher  sample  size,  it was  also associated  with  fewer  false  positives.
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Background:  Voxel-based  analyses  are  pervasive  across  the  range  of neuroimaging  techniques.  In the  case
of  perfusion  imaging  using  arterial  spin  labelling  (ASL),  a low  signal-to-noise  technique,  there  is  a  tradeoff
between  the  contrast-to-noise  required  to detect  a perfusion  abnormality  and its spatial  localisation.  In
exploratory  studies,  the  use  of  an  a priori  region  of  interest  (ROI),  which  has  the  beneﬁt  of averaging
multiple  voxels,  may  not  be justiﬁed.  Thus  the  question  considered  in  this  study  pertains  to  the  sample
size  that  is required  to detect  a voxel-level  perfusion  difference  between  groups  and  two  algorithms  are
considered.
New method:  Empirical  3T  ASL  data  were  acquired  from  25 older  adults  and  simulations  were  per-
formed  based  on the group  template  cerebral  blood  ﬂow  (CBF)  images.  General  linear  model  (GLM)
and  permutation-based  algorithms  were  tested for their  ability  to  detect  a predeﬁned  hypoperfused  ROI.
Simulation  parameters  included:  inter  and  intra-subject  variability,  degree  of  hypoperfusion  and  sample
size. The  true  positive  rate  was  used  as  a measure  of sensitivity.
Results:  For  a  modest  group  perfusion  difference,  i.e.,  10%,  37  participants  per  group  were  required
when  using  the  permutation-based  algorithm,  whereas  20 participants  were  required  for  the GLM-based
algorithm.
Comparison  with  existing  methods:  This  study  advances  the  perfusion  power  calculation  literature  by
considering  a  voxel-wise  analysis  with  correction  for multiple  comparison.
Conclusions:  The  sample  size  re
tion to increased  degree  of  hyp
inﬂuenced  by the  choice  of alg
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Table 1
Demographic and clinical data for the empirical, clinical ASL data.
Demographics Detail Mean values SD
Age years 74 8
Sex M/F  13/12
MoCA 22.3 6.6
Medical history: yes/no/unknown
Hypertension 14/9/2
Hypercholesterolemia 13/10/2
Type 2 diabetes 5/18/2
Stroke 5/18/2
Transient ischemic attack 2/21/2
Coronary artery disease 3/20/2
Dementia diagnosis 3/20/2
Note: Characteristics of the 25 participants used to generate the empirical templates
image (TR = 10 s, TE = 10 ms), as per current recommended guide-
lines (Alsop et al., 2014). CBF images were subsequently intensity70 A.M. Mersov et al. / Journal of Neu
. Introduction
Sensitivity analysis is an important aspect of any study design
nd particularly relevant to Arterial Spin Labelling (ASL) perfusion
agnetic resonance imaging (MRI) where the signal-to-noise ratio
an be low. ASL is commonly used to measure cerebral blood ﬂow
CBF) at a voxel-wise level and can be analysed in terms of sin-
le participants or across a group. CBF images are obtained by
agnetically labelling water in blood, a non-invasive approach
hat is well suited to probe a myriad of neurological conditions
Detre and Alsop, 1999; Théberge, 2008). In light of the grow-
ng interest in using ASL to measure perfusion in clinical and
esearch settings, recent work has focused on the reproducibility
nd sensitivity of the perfusion estimates (Huettel and McCarthy,
001; Parkes et al., 2004; Petersen et al., 2010). One consider-
tion that has received relatively limited attention is the choice
f sample size that is required to detect a perfusion effect of
nterest.
In a recent study, a Monte Carlo simulation was used to model
 10% perfusion difference between two groups and considering a
ingle voxel in the brain (Aslan and Lu, 2010). By normalising CBF
alues, the authors show that an 80% true-positive detection rate
an be achieved with 20 participants per group. Another sample
ize study used an ROI analysis to show that between 20 and 40
ubjects are required per group to detect a moderate 15% perfusion
ifference (Murphy et al., 2011).
In the current study we report a more generalised voxel-wise
pproach for scenarios in which ROIs are not known a priori, con-
equently requiring an analysis approach that accounts for the
ultiple comparison correction. One voxel-wise approach that
s appropriate for parametric or non-parametric data is permu-
ation testing (Nichols and Holmes, 2002). Permutation testing
as proven to be effective in diffusion tensor imaging (Nichols
nd Holmes, 2002; Karlsgodt et al., 2008; Weaver et al., 2009;
ullen et al., 2010), voxel based morphometry (Thomas et al.,
009), ASL (MacIntosh et al., 2010; MacIntosh et al., 2008) and
OLD neuroimaging studies (Arichi et al., 2010; Beissner et al.,
011; Jolles et al., 2011). The permutation approach allows for
he estimation of the null distribution and thereby empirically
orrects for family wise error associated with multiple com-
arisons (Nichols and Holmes, 2002). Another conventionally
sed voxel-wise approach is to use statistical parametric map-
ing (SPM) within a General Linear Model (GLM) framework.
n the case of SPM, multiple comparison correction can be per-
ormed by Gaussian Random Field (GRF) theory and by using both
he Z-statistic maximum height threshold for contiguous voxel
lusters as well as the cluster probability threshold to identify
igniﬁcant brain regions (Woolrich et al., 2009; Woolrich et al.,
004).
Given the increased number of ASL studies that perform whole-
rain voxel-wise analyses in both case-control (Alsop et al., 2000;
sllani et al., 2009; Fernández-Seara et al., 2012a; Yoshiura et al.,
009) and repeated measure designs (Borogovac et al., 2010;
hao et al., 2010; Kim et al., 2006), it is important to con-
ider the performance of analysis approaches that are used to
etect voxel-wise perfusion changes. The current study involves
 characterisation of the minimum number of participants that
re required to detect a particular percent hypoperfusion (PHP)
ffect in a case-control design. Simulated perfusion data are gen-
rated based on an ASL dataset of elderly adults with ischemic
mall vessel disease pathology, from which it is possible to esti-
ate clinically realistic inter and intra-subject variability. The
ypoperfusion scenarios are restricted to grey matter voxels
onsistently estimated across the empirical ASL dataset and a
omparison of two common voxel-wise analysis algorithms is
erformed.to  be used in the simulation.
2. Materials and methods
2.1. Participants
The study was  conducted with approval from the Sunnybrook
Research Institute Research Ethics Board. Twenty-ﬁve older adults
(mean age 74 ± 8; 13 men, 12 women) were recruited from a
neurology memory clinic at Sunnybrook hospital to a study on
cerebrovascular disease. Informed consent was obtained from all
participants. Individuals reported subjective cognitive complaints
and had a history of a cerebrovascular event or a neurodegener-
ative proﬁle.  Participants had pre-existing risk factors such as a
history of transient ischemic attack or moderate amounts of white
matter disease ascertained from structural MRI. The breakdown
of these demographics, including cardiovascular comorbidities, are
provided in Table 1.
2.2. MRI  acquisition
ASL perfusion images were acquired on a 3 Tesla Philips
Achieva MRI  system using body coil transmission and an 8-channel
receiver head coil. Pseudo-continuous arterial spin labelling
(pcASL) images were acquired with echo planar imaging (EPI)
(TR/TE = 4000/9.7 ms,  FOV 19 × 19 × 9 cm3, 64 × 64 × 18 matrix,
voxel dimensions 3 × 3 × 5 mm3, 1650 ms  labelling duration, post-
label delay = 1600 ms,  35 control and tag pairs, scan duration
4:48 min) (Van Osch et al., 2009). The label was  prescribed 80 mm
below the lowest pcASL slice, perpendicular to the internal carotid
arteries and typically between C1 and C2 cervical vertebrae.
2.3. Pre/post-processing
Control and tag images were separated from the ASL dataset
and MCFLIRT was  used to align the time series of images. After
registering the mean control and tag images to a common refer-
ence space using FLIRT (Jenkinson et al., 2002) with seven degrees
of freedom, the mean tag image was  subtracted from the mean
control image to produce a CBF-weighted difference image. Each
participant’s CBF image was  divided by a proton density weightednormalised and then aligned using MCFLIRT with six degrees of
freedom to the group mean image, which served as the group tem-
plate. All processing was  performed using FMRIB Software Library
(FSL).
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Fig. 1. Top: representative CBF axial images from six of the 25 subjects.
Bottom (left): Mean CBF template CBF (global mean = 45 ml/100 mg/min,
SD = 13 ml/100 mg/min), averaged from the 25 subject CBF images following coreg-
istration in FSL. The simulated ROI is superimposed in the occipital-parietal cortex,
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womprised of 70 contiguous voxels. Bottom (right): Standard deviation template
cross the group (CBF) as generated in FSL, expressed as a percentage of the average
lobal CBF value (global mean SD = 33%).
.4. Simulation of CBF images
Empirical data were used to generate a group mean CBF (CBF)
nd a group standard deviation (SD, CBF) image (Fig. 1). Global,
rey matter and white matter perfusion mean signal in the empir-
cal group mean template were 26 (SD 8), 31 (SD 6), and 22
SD 8) ml/100 mg/min, respectively. CBF was scaled to a global
evel of 45 ml/100 mg/min, which was based on an expected grey
atter CBF level for older adults (Last, 2007) and is consistent
ith other clinical reports of similar clinical elderly populations
ith Alzheimer’s Disease or Parkinson’s Disease and Dementia
iagnoses (Last, 2007; Chen et al., 2012; Le Heron et al., 2014;
ernández-Seara et al., 2012b; Alexopoulos et al., 2012; Melzer
t al., 2011). Both CBF and CBF were used to set the parameters
or the following simulation approach.
Simulation of a case group included the addition of global signal
ariation at the voxel level prior to imposing a regional hypoper-
usion, as reﬂected in the Supplementary Figure process diagram.
or a given case subject, this global voxel-wise variability was sim-
lated by assuming that every voxel value comes from a normal
istribution of  speciﬁed by the value of CBF at that voxel and
  speciﬁed by the value of CBF at the same voxel. Thus every
th voxel value was imposed independently by generating a ran-
om number from a normal distribution N(CBF(i), CBF(i)). A
hapiro-Wilk test was performed on every voxel in the masked
BF image (22,077 voxels) to test the distribution across the 25
mpirical subjects. 14.9% of voxels deviated from a group 2-tailed
aussian distribution at p > 0.05 (13.5% in grey matter, 10.3% in
hite matter).ce Methods 245 (2015) 169–177 171
Following the addition of global voxel variability, the val-
ues within a 70-contiguous-voxel (3.15 ml)  parietal-occipital ROI
(Fig. 1B) were reassigned to model an imposed hypo-perfusion sce-
nario (corresponding to the second last procedural step as seen in
the Supplementary Figure). The mean CBF in the ROI was reduced
by 5–20% in increments of 2–3%, and from 20% down to 30%,
40%, and 50% in increments of 10%. Thus ten hypoperfusion sce-
narios were generated for the simulations. Within-ROI variability
was modeled by setting spatial standard deviation to be 0.05,
0.15, and 0.40 times the imposed ROI mean, which is consistent
with standard deviations observed across grey matter (Petersen
et al., 2010; Aslan et al., 2010). The hypoperfusion scenarios were
designed to sample a larger proportion of low to modest cases
and fewer cases of dramatic hypoperfusion (i.e., >40% decrease in
perfusion). Inter-subject variability in the degree of percent hypo-
perfusion imposed in the case group was kept low (at most 2.2%)
to model the scenario in which the case group has a relatively
consistent hypoperfusion syndrome.
Simulation of control subjects involved a single step, as reﬂected
above, which was the addition of global voxel-wise variability. In
this manner the mean CBF in the ROI region of control subjects
reﬂected that of the empirical CBF (51 ml/100 mg/min) and the
resulting inter-subject variability in this value was at most 4.7%
due to the addition of global voxel-wise variability. The ROI per-
cent hypoperfusion scenarios imposed in the case group were thus
relative to the empirical CBF value of the same ROI in controls. A
2 mm  FWHM Gaussian smoothing kernel was applied on both case
and control CBF datasets in order to introduce spatial autocorrela-
tion. The Gaussian smoothing had the effect of diffusing the strictly
imposed hypoperfusion values above to generate a distribution of
hypoperfusion scenarios.
Varying global voxel-wise variability levels in both control and
case subjects were simulated by varying the multiple of CBF(i)
(used in the ﬁrst step to indicate the sigma value of the normal dis-
tribution from which voxel values were extracted) from 1 to 2 in
increments of 0.125 (total of 9 noise levels). Upper case hypoper-
fusion scenarios of 40% and 50% were sampled less densely with
only three increments of 1, 1.5, and 2.
The smallest sample size that was considered was N = 8 per
group (i.e., eight patients, eight controls). Sample size was incre-
mented by four until the largest sample size of 72 per group, while
keeping the number of participants equal between groups, result-
ing in a total of 17 different sample sizes. The largest hypoperfusion
scenarios of 40 and 50 were sampled less densely with largest sam-
ple size of 36 per group, resulting in a total of eight different sample
sizes.
Overall, for the eight moderate hypoperfusion scenarios at nine
global voxel-wise variability levels, at three levels of ROI voxel-
wise variability there is a total of 216 case-control scenarios. Each
scenario was  tested at 17 different sample sizes, giving 3672 total
scenarios. Additionally, the two  upper case perfusion cases at
three global voxel-wise variability levels and at three levels of ROI
voxel-wise variation add an additional 18 case-control scenarios,
each at eight different samples size (144 upper case-control sce-
narios). This work therefore examines a total of 3816 simulated
case-control scenarios. Representative simulated case and control
images following Gaussian kernel smoothing are shown in Fig. 2.
2.5. Voxel-wise statistical analysis
To compare the results of the two  different algorithms, the 3816
simulated case-control scenarios were run separately in a voxel-
wise whole-brain unpaired analysis using two algorithms that are
part of the FMRIB software library (FSL Version 4). Algorithms were
run in a Linux environment (Ubuntu 11.04). The permutation test-
ing algorithm, called Randomise, involved 5000 permutations and
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Pig. 2. Representative simulated case (top) and control (bottom) CBF images follo
iddle), and high (top left) ROI percent hypoperfusion (ROI HP) and a CBF(i) mult
ontrols  for reference. Variability within the ROI (ROI var) is expressed as the perce
 Threshold Free Cluster Enhancement (TFCE) to correct for mul-
iple comparisons with default cluster parameters of H = 2 (power
f the cluster height), E = 0.5 (power of cluster extent), and C = 6
degree of connectivity) (Smith and Nichols, 2009). Voxels with cor-
ected p-value <0.05 were considered signiﬁcant. The second group
nalysis method was an SPM approach known as FLAME (FMRIB’s
ocal Analysis of Mixed Effects), run within the fMRI Expert Analysis
ool (FEAT). The SPM analysis was carried out in the conventional
anner without the inclusion of voxelwise estimates of variance
rom the subject level data. Cluster thresholding with cluster Z-
core > 1.96 and cluster signiﬁcance threshold of p-value < 0.05 was
pplied to correct for multiple comparisons.
.6. Evaluation
The percentage of voxels within the case ROI that were detected
s being signiﬁcantly different from controls was termed the true
ositive rate (TPR). For each simulated scenario, the ROI was
etected as signiﬁcant if 35 out of the 70 ROI voxels were below
he corrected p-value threshold of p = 0.05. A tolerance of one voxel
as permitted for this TPR threshold of 50%, i.e., 50 ± 2%, to account
or round off error on the corrected p-value estimates. The TPR
as used to generate power curves and compare across sample
ize (N), PHP in the ROI, and choice of algorithm. The false pos-
tive rate (FPR), deﬁned here as the percentage of voxels outside
he ROI classiﬁed as signiﬁcant after multiple comparison correc-
ion, was also monitored. From the power curves, the minimum
 required for 50% TPR was extracted and plotted against the
HP for every simulated scenario. To model the dependence ofGaussian kernel smoothing. Case subject images for low (top right), medium (top
f 1, 1.5, and 2 (increasing “noise” level). The ROI CBF mean value is indicated in the
 SD of the ROI CBF mean value.
the minimum N on the PHP, curve ﬁtting was  performed with a
non-linear regression model using iterative least squares estima-
tion in MATLAB. Two exponential curves were applied with three
parameters to estimate: N = A1 exp(−A2 × PHP) + A3 (Model A) and
N = B1exp(−B2 × PHP2) + B3 (Model B). Models were compared to a
linear ﬁt. An F-statistic was used to compare the ratio of the residual
sum of squares to the parameter gain between the simpler linear
model and the more complex Model A or B. The post-ﬁtting coefﬁ-
cient covariance matrix and the residuals were used to determine
95% conﬁdence intervals on the ﬁtted coefﬁcients.
3. Results
3.1. Simulated group characteristics
The global, grey matter, and white matter values in the ﬁnal
simulated images and their corresponding ranges of spatial vari-
ability across subjects were 44 (14–17), 52 (14–17), and 37(14–17)
ml/100 mg/min. These values are within range of what is com-
monly reported for similar elderly populations (Last, 2007; Chen
et al., 2012; Le Heron et al., 2014; Fernández-Seara et al., 2012b;
Alexopoulos et al., 2012; Melzer et al., 2011). Out of the 234 sim-
ulated hypoperfusion scenarios, 38 did not achieve the 50% (±2%)
TPR threshold criterion in the range of the 17 sample sizes con-
sidered. Thirty-three of these 38 produced non-signiﬁcant ﬁndings
in both FEAT and Randomise and corresponded to scenarios where
the perfusion difference between case and control groups was  rela-
tively small. The average PHP of the case group in these 33 scenarios
was 4.2 (SD 2.7), while the variability within the ROI was  25% (SD
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Table  2
Characteristics of the simulated data-set.
Case Control
Median SD Range Median SD Range
Inter-subject SD of ROI CBF means 1.9 1.4 (0.4–6.5) 4.9 1.3 (2.8–6.9)
ROI  voxel-wise Variability 14 3 (10–23) 24 4 (17–31)
PHP  13 9 (2–42) – – –
Note: Characteristics of the 196 simulated scenarios that produced a signiﬁcant group perfusion difference. The mean CBF value in each subject’s ROI was computed and the
inter-subject standard deviation of the ROI means across a group of N subjects was recorded. The distribution of values within the ROI was recorded as the ROI voxel-wise
variability and presented as the percent standard deviation of the ROI mean. PHP is the p
in  percent units. The table presents the median, standard deviation (SD), and range acros
units.
Fig. 3. Distribution of the percent ROI hypoperfusion value across the 196 simu-
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hated scenarios, characterised by minimum = 1.6%, maximum = 42%, mean = 15%, and
edian = 13%. The number of simulated scenarios in each bin (left to right): 48, 65,
1,  24, 9, and 9.
) of the mean in controls and 15% (SD 3) in cases. The additional
 out of 38 scenarios did not achieve 50% TPR for Randomise only.
he PHP of the case group in these 5 scenarios was on average 5
SD 4), while variability within the ROI was 29% (SD 3) of the mean
n controls and 18% (SD 3) in cases. The combination of low PHP in
he case group and high voxel-wise variability within the ROI was
ikely to reduce the sensitivity in detecting the imposed regional
erfusion difference.
The remaining 196 scenarios produced a signiﬁcant outcome
>50 ± 2% TPR) in at least 1 of the 17 sample sizes and are thus
onsidered in more detail herein. The distribution of these 196 case-
ontrol scenarios is presented in Fig. 3, in terms of the PHP across
he case group, with additional characteristics speciﬁed in Table 2.
ote that the low inter-subject standard deviation in the ROI means
medians of 4.9% in controls, 1.9% in cases) was an attempt to model
 “best-case scenario” of a fairly homogenous group sample.
.2. TPR vs. FPR curves
Following analysis the values of TPR and FPR were computed
rom each of the 3816 case-control scenarios and plotted against
ne another in Fig. 4. For the purpose of Fig. 4, the entire 234
cenario data-set is considered. The distinction between “low-
edium” and “high” sample sizes show an overall shift to higher
PR when higher sample size was used. FPR also increases with
HP but remains remarkably low, well below 1% for both FEAT and
andomise. Compared to Randomise, FEAT demonstrates larger
ariability in the curve pattern with higher TPRs overall but also
igher FPR data points.ercent hypoperfusion in the mean ROI CBF in the case group relative to the control,
s the entire simulated 196 case-control scenario database. All values are in percent
3.3. Dependence on sample size
For the 196 simulated scenarios, the minimum N required to
reach 50% sensitivity is plotted as a function of PHP for both algo-
rithms separately (Fig. 5). The same data were also binned by PHP
(Fig. 5C) to contrast the algorithm requirements on sample size.
Based on the average across each PHP range, 50% (±2%) sensitivity
is reached for PHP in the ranges of 1.6–8.3, 8.3–15, 15–22, 22–28,
28–35, and 35–42 at N of 59, 32, 17, 11, 9, and 8 per group when Ran-
domise was  used, while the comparative N requirements for FEAT
when used on the same dataset are signiﬁcantly lower (Table 3).
For each PHP range, a non-parametric Wilcoxon rank sum test was
done on the N requirements of Randomise and FEAT. The statistic
was based on the number of simulated scenarios in each PHP range.
The resulting p-values indicated signiﬁcantly higher N require-
ments to achieve 50% (±2%) sensitivity in Randomise for PHP <25%
(Fig. 5C). There is no difference between the algorithms for PHP
>25%. Both algorithms produced minimum simulated sample size
requirement of N = 8 when PHP >42%.
A test was done for a linear regression effect of ROI hypoper-
fusion on sample size. The linear model was signiﬁcant (p < 0.0001)
(for FEAT and Randomise, respectively: adjusted R2 = 0.38, 0.58,
PHP regression t-stat = −16.3, −10.6, for 194 degrees of freedom).
ROI spatial variability and the global voxel-wise variability were
subsequently included in the regression and were signiﬁcant pre-
dictors of sample size (p < 0.01) For Randomise the statistics were
t = 2.80, p = 0.006 and t = 2.6, p = 0.01 for ROI and global variabil-
ity, respectively, while for FEAT only ROI variability was signiﬁcant
(t = 3.3, p = 0.001) whereas global variability was not (p = 0.38). The
three variable regression achieved R2 = 0.41, 0.61 for FEAT and
Randomise, respectively. As ROI hypoperfusion was the primary
predictor of sample size, it was further included in the non-linear
regression models (Models A and B described above). Both Model
A and B were signiﬁcant (p < 0.0001) and improved model ﬁts in
both algorithms, FEAT (R2 = 0.67 (A), R2 = 0.71 (B)) and Randomise
(R2 = 0.79 (A), R2 = 0.81 (B)).
The results of the non-linear regression analysis are shown in
Table 4. The F-statistic showed both Model A and B achieved a
more signiﬁcant ﬁt (p-value < 0.00001) when compared to the lin-
ear model (p-value < 0.00001), yet differences between Model A and
B were not signiﬁcant (p-value > 0.3). From the non-linear curves it
is estimated that a minimum of 37 and 20 subjects per group are
required to detect a 10% PHP using Randomise and FEAT, respec-
tively (Table 5).
4. Discussion
The current work presents a novel simulation approach to
test the sensitivity of two commonly used algorithms that are
designed to detect perfusion differences at a voxel-wise level
after correcting for multiple comparisons. First, we observed a
consistent exponential drop-off in the minimum sample size
174 A.M. Mersov et al. / Journal of Neuroscience Methods 245 (2015) 169–177
Fig. 4. FEAT (bottom) and Randomise (top) TPR vs. FPR curves compared. The TPR is plotted against the FPR for all 3816 scenarios. Left: scenarios of N < 36. Right: scenarios
N  > 36. Thresholds of 10% and 20% ROI hypoperfusion were applied to the data, as shown by the colour scheme.
Fig. 5. The cohort size that is required to achieve 50% sensitivity in the simulated ROI is plotted as a function of the degree of hypoperfusion for Randomise (A) and FEAT (B).
The  data are binned with mean percent hypoperfusion per bin indicated on the x-axis (C), where asterisks indicate p-values generated from non-parametric Wilcoxon rank
s  5C is 
S on 2.4
e
r
t
n
l
T
S
N
num  test on the two  algorithms; <0.0000001 (*), <0.0001 (**), >0.1 (***). Data for Fig.
upplementary Figure: The diagram supplements the methods described in Secti
mpirical templates.
equired to detect a perfusion difference between the groups as
he PHP in the case group increased. Second, there were sig-
iﬁcant differences between the group analysis algorithms. At
ow PHP’s, Randomise required ∼1.6 times larger sample sizes
able 3
ample size requirements for 50% TPR.
Range of ROI PHP Mean ROI PHP # Simulated scen
1.6–8.3 5 48 
8.3–15  12 65 
15–22  18 41 
22–28 25 24 
28–35  32 9 
35–42  39 9 
ote: N subjects per group (SD) required in an unpaired “case-control” design for 50% sen
umber  of simulated scenarios falling within each range of ROI percent hypoperfusion (arecorded in Table 2.
 and presents the steps taken to simulate the Case and Control images from the
compared to FEAT. This discrepancy held for moderate PHP’s,
but the algorithms were equally adept at detecting PHP’s >25%.
Third, Randomise provided fewer false positives compared to
FEAT.
arios Randomise N for 50% FEAT N for 50%
59 (12) 35(14)
32 (15) 17 (8)
17 (6) 10 (3)
11 (3) 8 (0)
9 (2) 8 (0)
8 (0) 8 (0)
sitivity compared between two algorithms. The N value is an average based on the
 total of 196 across all bins). See bar graph Fig. 5C.
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Table  4
Estimation of model parameters.
Parameter Randomise FEAT
Mean 95% CI Mean 95% CI
Model A A1 110 97–122 74 60–89
A2  0.119 0.096–0.142 0.162 0.124–0.2
A3  4 0.178–9 5.9 3.1–8.6
Model  B B1 67 62–73 43 37–49
B2  0.0085 0.007–0.01 0.0125 0.0094–0.0157
B3  10 
Note: Parameter estimates for two exponential models (Model A, N = A1 exp (−A2 × PHP) + A
Curve  ﬁtting was performed with a non-linear regression method of least squares optimi
Table  5
Sample size estimations from ﬁtted models.
PHP Randomise FEAT
Model A Model B Model A Model B
6% 58 59 33 35
10%  37 39 20 20
15%  22 20 12 11
Note: Minimum N for 50% TPR at low to moderate PHP case-control difference,
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where BOLD MRI  acquisition was used (Desmond and Glover, 2002;stimated by Models A and B.
The TPR vs. FPR curves showed a positive association between
PR and the degree of hypoperfusion. Remarkably, the number of
alse positives was less than 0.5% for both algorithms, which is
 testimony to the rigorous methodology that was used and the
pplied multiple-comparison correction in both algorithms. We
ote that the choice of normally-distributed noise in the simu-
ations without a representation of commonly-encountered data
pikes may  have inﬂuenced the observed low false positive rate,
eaning the results here may  be optimistic relative to an empirical
erfusion group analysis. Nevertheless, the data represented in the
PR data (Fig. 4) demonstrate a far higher FPR in FEAT, as much as
ix times that of Randomise, under equivalent circumstances. This
ould be interpreted as the baseline FPR detection inherent in each
lgorithm and could suggest the multiple-comparison correction
ethod employed by the permutation-approach in Randomise is
ore effective than the cluster-based correction used in FLAME.
he positive correlation between sample size and FPR is likely due
o the increased chance of false positive detection with a greater
ool of Gaussian distributed noise in the image.
The dependence of the sample size required to detect 50% of the
OI on the degree of ROI hypoperfusion is shown to be signiﬁcantly
etter approximated by both forms of the proposed exponential
odels when compared to a linear ﬁt (p-value < 0.00001). As seen
n Table 5, the two models generate very similar numbers. Accord-
ng to the ﬁtted models, a minimum of 37 and 20 subjects will be
equired per group for detecting a moderate 10% hypoperfusion
n a case-control design using Randomise and FEAT, respectively
Table 5). The results from the current study suggest that ASL per-
usion case-control studies with sample sizes of 10–20 subjects per
roup may  lack sufﬁcient power to detect low or modest regional
ypoperfusion effects at a voxel-wise level that are independent of
ther covarying effects such as atrophy. In cases where a paramet-
ic distribution of the data cannot be assumed and therefore using
EAT is not appropriate (since it assumes normality), higher sample
izes should be considered if Randomise is used instead.
Although the simulated range of PHP’s was consistent with clin-
cal ASL studies that reported perfusion differences between 8% and
5% (Alsop et al., 2000; Kim et al., 2006; Alexopoulos et al., 2012;
ao et al., 2007) relative to controls (Table 3), there were a few
ssumptions in the simulation design that may  limit the generalis-
bility of the ﬁndings.7–13 8 6–10
3 and Model B, N = B1 exp (−B2 × PHP2) + B3) ﬁtted on Fig. 5. CI = conﬁdence interval.
zation in Matlab.
First, our simulated ROI was  situated in the posterior parietal
region, near the angular gyrus, a neuroanatomical region that has
been reported in multiple perfusion and glucose metabolism stud-
ies to be not only associated with Parkinson’s Disease and Dementia
as well as Mild Cognitive Impairment but also to be predictive of
Alzheimer’s Disease (Yoshiura et al., 2009; Le Heron et al., 2014;
Alexopoulos et al., 2012; Melzer et al., 2011; Kamagata et al., 2011;
Landau et al., 2011; Kikuchi et al., 2001; Song et al., 2014). How-
ever future work could further investigate the effect that the ROI
size and number of ROIs have on sample size requirements. Second,
inter-subject variability within the hypoperfused ROI was designed
to be low (1.9%, Table 2), a scenario that would translate clinically
to a homogeneous perfusion abnormality among the patient group.
Similarly, global perfusion differences or inter-subject variation in
the ROI location were not introduced. It is important to note that
aside from ROI hypoperfusion, the degree of ROI spatial variability
and the global voxel-wise variability were also moderately predic-
tive of sample size (p ≤ 0.01) in the linear regression but were not
accounted for in the exponential models because their inﬂuence
on the model ﬁt were slight in our case. Yet this highlights a need
for investigating further the effects that such parameters may  have
on a region’s detectability. We would also like to point out that
the data was  simulated using a normal distribution even though
a small proportion of grey matter voxels in the empirical dataset
were found not to be normality distributed. This would have lit-
tle to no effect on the randomise approach but presumably may
impact the GLM approach where a normal distribution is assumed
by the algorithm. Third, we  assumed spatially uniform noise within
subjects (i.e., no CBF intensity spikes due to a poor coregistration
or image artifacts, as examples). Fourth, our TPR criteria of 50%
meant that there may  have been “successful” simulation cases that
had 50% false negatives. This criterion was chosen to approximate
patient heterogeneity due to differences in anatomy, brain tissue
volume or registration issues. Post-hoc we  did observe that a TPR
criterion of 80% produced greater demands on sample sizes across
the PHP range. Future work could address the effect of varying the
sensitivity demands depending on the size of ROI that needs to be
detected. Lastly, future work on ASL effect sizes could also resam-
ple from empirical data directly. This is now feasible given that
there are published ASL studies with sample sizes well beyond 100
participants, such as from multi-site studies (Petersen et al., 2010),
clinical exams (Tan et al., 2012) or repositories that are destined to
be publicly available (Satterthwaite et al., 2014).
Despite some limitations, this study adds to the literature on sta-
tistical inference in functional neuroimaging and the results were in
a range established in previous sample-size estimations (Aslan and
Lu, 2010; Murphy et al., 2011; Desmond and Glover, 2002; Murphy
and Garavan, 2004). Sample size requirements determined using
FEAT were comparable to previous work on sample-size estimationMurphy and Garavan, 2004). For a paired design scenario, Desmond
& Glover (Desmond and Glover, 2002) estimate subject variability
and percent signal change from a block design fMRI experiment
1 roscie
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A 〈http://www.ncbi.nlm.nih.gov/pubmed/21448943〉.76 A.M. Mersov et al. / Journal of Neu
nd use these parameters to drive a simulation of subject time
eries. Assuming a within-subject percent signal change of 0.5%
nd employing a standard random effects analysis (using a paired t-
est), they show that 24 subjects are needed to ensure 80% power for
5% conﬁdence at the single voxel level. A BOLD-based fMRI study
or an unpaired design scenario reported that 20 subjects per group
ould be sufﬁcient for 80% power in reproducing truly activated
oxels (Murphy and Garavan, 2004). A study based on ASL data has
eported similar numbers of 20 subjects per group for a moderate
0% group perfusion difference at 80% power (Aslan and Lu, 2010),
r between 20 to 40 subjects per group from an ROI analysis in Mur-
hy et al.  (Murphy et al., 2011). The higher sample size requirement
n Randomise as compared to previous sample size studies may  be
onsequence of the stringent permutation approach applied to con-
rol for multiple comparisons. The permutation approach requires
ne less assumption about the data compared to GLM, since a nor-
al  distribution is not a requirement for the former but is for the
atter. Instead, the null distribution is categorised through the com-
utationally expensive process of testing permutations on the data.
ifferences between the two approaches may  reﬂect differences in
he degree of freedom, with permutations using more degrees of
reedom compared to GLM, or false assumptions of normality. The
atter reason is one of the main arguments in favour of the per-
utation approach, as described by others (Nichols and Holmes,
002; Bullmore et al., 1999). It remains difﬁcult to compare the
umbers reported above with those from previous work directly,
s this study is the ﬁrst to analyze the demands on sample size
ased on the ability of common algorithmic approaches to detect
 regional perfusion change while applying multiple comparison
orrection.
. Conclusion
This study develops the means to estimate the sample size that
ould be required to detect a particular perfusion abnormality at
 voxel-wise level, using commonly implemented algorithms that
nherently correct for multiple comparisons. This study is relevant
iven that there is growing interest in ASL as a non-invasive per-
usion MRI  technique that can be used for clinical neuroimaging
nvestigations. There is therefore an onus to develop more sophis-
icated ways to perform group analysis on perfusion images, but
lso a need to test the effectiveness of speciﬁc group analysis
pproaches in detecting possible perfusion changes.
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